Their complaint states the final rule “purports to further that objective [of bringing down prices] but will instead frustrate it – by misleading patients about their out-of-pocket costs for prescription drugs in a manner that even the Department of Health and Human Services admits may ‘confuse’ and ‘intimidate’ patients”.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Uh oh, seems like the President has touched a nerve in BigPharma. Good.
About time someone was brave enough to take on the drug companies 👏
Persian famine of 1917–1919 The .'Persian holocaust.' !
Time for RegimechangeinUS AwaywithTrump realDonaldTrump